美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=PARICALCITOL"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
PARICALCITOL 204948 002 ANDA PARICALCITOL CAPSULE;ORAL 2MCG No No 2016/10/07 2016/10/07 MARKSANS PHARMA Prescription
PARICALCITOL 204948 003 ANDA PARICALCITOL CAPSULE;ORAL 4MCG No No 2016/10/07 2016/10/07 MARKSANS PHARMA Prescription
PARICALCITOL 206699 001 ANDA PARICALCITOL SOLUTION;INTRAVENOUS 0.002MG/ML (0.002MG/ML) No No 2017/03/09 2017/03/09 AMNEAL PHARMS CO Prescription
PARICALCITOL 206699 002 ANDA PARICALCITOL SOLUTION;INTRAVENOUS 0.005MG/ML (0.005MG/ML) No No 2017/03/09 2017/03/09 AMNEAL PHARMS CO Prescription
PARICALCITOL 206699 003 ANDA PARICALCITOL SOLUTION;INTRAVENOUS 0.01MG/2ML (0.005MG/ML) No No 2017/03/09 2017/03/09 AMNEAL PHARMS CO Prescription
PARICALCITOL 207692 001 ANDA PARICALCITOL SOLUTION;INTRAVENOUS 0.01MG/2ML (0.005MG/ML) No No 2017/10/16 2017/10/16 EPIC PHARMA LLC Discontinued
PARICALCITOL 203897 001 ANDA PARICALCITOL SOLUTION;INTRAVENOUS 0.002MG/ML (0.002MG/ML) No No 2017/11/02 2017/11/02 RISING Discontinued
PARICALCITOL 203897 002 ANDA PARICALCITOL SOLUTION;INTRAVENOUS 0.005MG/ML (0.005MG/ML) No No 2017/11/02 2017/11/02 RISING Prescription
PARICALCITOL 203897 003 ANDA PARICALCITOL SOLUTION;INTRAVENOUS 0.01MG/2ML (0.005MG/ML) No No 2017/11/02 2017/11/02 RISING Prescription
PARICALCITOL 205982 001 ANDA PARICALCITOL SOLUTION;INTRAVENOUS 0.002MG/ML (0.002MG/ML) No No 2018/10/09 2018/10/09 EUGIA PHARMA Prescription
PARICALCITOL 205982 002 ANDA PARICALCITOL SOLUTION;INTRAVENOUS 0.005MG/ML (0.005MG/ML) No No 2018/10/09 2018/10/09 EUGIA PHARMA Prescription
PARICALCITOL 205982 003 ANDA PARICALCITOL SOLUTION;INTRAVENOUS 0.01MG/2ML (0.005MG/ML) No No 2018/10/09 2018/10/09 EUGIA PHARMA Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database